ABSTRACT
In this paper, several techniques and models proposed the spread of coronavirus (Covid-19) and determines approximately the final number of coronavirus infected cases as well as infection point (peak time) in Algeria. To see the goodness of the predicting techniques, a comparative study was done by calculating error indicators such as Root-Mean-Square Error (RMSE) and the sum of squared estimate of errors (SSE). The main technique used in this study is the logistic growth regression model widely used in epidemiology. The results only relate to the two months from the beginning of the epidemic in Algeria, which should be readjusted by integrating the new data over time, because hazardous parameters like possible relaxations (decrease of vigilance or laxity of society) can affect these results and generally cause a time lag in the curve. Hence, a re-estimation of the curves is always requested.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
/
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
/
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.